These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 5259366)

  • 1. Objective and subjective tests in measuring response to CNS drugs in normal subjects.
    Bishop MP; Guthrie MB; Hornsby LD
    J Clin Pharmacol J New Drugs; 1969; 9(5):308-14. PubMed ID: 5259366
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dextroamphetamine, pentobarbital, chlorphentermine, and placebo on the alpha blocking response in normal subjects.
    Delamonica E; Shaffer JW; Brown CC; Kurland AA
    J New Drugs; 1966; 6(4):224-8. PubMed ID: 5338654
    [No Abstract]   [Full Text] [Related]  

  • 3. Objective effects of dexamphetamine and amobarbital and their relations to psychasthenic personality traits.
    Ideström CM; Schalling D
    Psychopharmacologia; 1970; 17(5):399-413. PubMed ID: 4942686
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of drugs in psychiatric interviews: some interpretations based on controlled experiments.
    Stevenson I; Buckman J; Smith BM; Hain JD
    Am J Psychiatry; 1974 Jun; 131(6):707-10. PubMed ID: 4151258
    [No Abstract]   [Full Text] [Related]  

  • 5. Single dose of prednisone does not induce amphetamine-like subjective effects in healthy subjects.
    Warot D; Danjou P; Payan C; Rocher J; Brialy N; Puech AJ
    Therapie; 1995; 50(4):307-12. PubMed ID: 7482385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V; Venitz J
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological tests: practice effect in geriatric patients.
    Lehmann HE; Ban TA; Kral VA
    Geriatrics; 1968 Feb; 23(2):160-3. PubMed ID: 5635751
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychological effects of drugs. A factor analytic approach.
    Nash H; Stone GC
    J Nerv Ment Dis; 1974 Dec; 159(6):444-8. PubMed ID: 4436669
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of placebo, Dexamyl, and Lucofen on moods, emotions, and motivations.
    Cameron JS; Specht PG; Wendt GR
    J Psychol; 1967 Jul; 66(2):199-209. PubMed ID: 4864827
    [No Abstract]   [Full Text] [Related]  

  • 10. A methodology using subjective responses to discriminate between pharmaceutical preparations.
    Free SM; Guthrie M
    J Clin Pharmacol J New Drugs; 1968; 8(3):164-71. PubMed ID: 5241339
    [No Abstract]   [Full Text] [Related]  

  • 11. [The psychic effect of ibogaline hydrochloride (alkaloid from Tabernanthe iboga Baill)].
    Schmid PB
    Arzneimittelforschung; 1967 Apr; 17(4):485-90. PubMed ID: 5632444
    [No Abstract]   [Full Text] [Related]  

  • 12. EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers.
    Fink M; Shapiro DM; Itil TM
    Psychopharmacologia; 1971; 22(4):369-83. PubMed ID: 5133438
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistence of dose related behaviour in mice.
    Dorr M; Steinberg H; Tomkiewicz M; Joyce D; Porsolt RD; Summerfield A
    Nature; 1971 May; 231(5298):121-3. PubMed ID: 4930092
    [No Abstract]   [Full Text] [Related]  

  • 14. The evaluation of the health state of the workers occupationally exposed to low concentration of carbon disulphide (CS2). Part two: The complex way of the examination of the central nervous system (CNS).
    Chrostek Maj J; Czeczótko B
    Przegl Lek; 1995; 52(5):252-6. PubMed ID: 7644690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function.
    Cameron OG; Abelson JL; Young EA
    Biol Psychiatry; 2004 Dec; 56(11):875-83. PubMed ID: 15576065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a sustained-release d-amphetamine-amobarbital preparation in the treatment of obesity.
    MICHAILE KI; SHAPIRO RP
    Int Rec Med Gen Pract Clin; 1956 Oct; 169(10):638-41. PubMed ID: 13366519
    [No Abstract]   [Full Text] [Related]  

  • 17. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation.
    Wesensten NJ; Killgore WD; Balkin TJ
    J Sleep Res; 2005 Sep; 14(3):255-66. PubMed ID: 16120100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dexamphetamine, amylobarbitone sodium and their mixture on sensory contingent bar pressing behaviour in the rat.
    Glow PH; Russell A
    Psychopharmacologia; 1973 Jul; 31(3):239-51. PubMed ID: 4732727
    [No Abstract]   [Full Text] [Related]  

  • 19. Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle.
    Bech P
    Acta Psychiatr Scand; 2009 Nov; 120(5):400-9. PubMed ID: 19807722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay procedure for spectrophotometric determination of dextroamphetamine sulfate and amobarbital formulated into timed-release capsules.
    De Fabrizio F
    J Pharm Sci; 1972 Jan; 61(1):101-2. PubMed ID: 5058621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.